NasdaqGM - Nasdaq Real Time Price USD
Septerna, Inc. (SEPN)
6.69
-0.26
(-3.74%)
At close: May 9 at 4:00:00 PM EDT
6.69
0.00
(0.00%)
After hours: May 9 at 4:05:06 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.45 | -0.45 | -1.88 | -2.53 |
| Low Estimate | -0.55 | -0.5 | -2.1 | -3.08 |
| High Estimate | -0.33 | -0.36 | -1.48 | -1.48 |
| Year Ago EPS | -- | -- | -7.26 | -1.88 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 4 |
| Avg. Estimate | -- | -- | 350k | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 1.4M | -- |
| Year Ago Sales | -- | -- | 1.07M | 350k |
| Sales Growth (year/est) | -- | -- | -67.44% | -100.00% |
Earnings History
| Currency in USD | 9/30/2024 | 12/31/2024 |
|---|---|---|
| EPS Est. | -- | -0.69 |
| EPS Actual | -8.4 | -0.64 |
| Difference | -- | 0.05 |
| Surprise % | -- | 6.80% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.45 | -0.45 | -1.88 | -2.53 |
| 7 Days Ago | -0.5 | -0.53 | -2.21 | -2.63 |
| 30 Days Ago | -0.5 | -0.53 | -2.21 | -2.63 |
| 60 Days Ago | -0.59 | -0.67 | -2.5 | -3.15 |
| 90 Days Ago | -0.59 | -0.67 | -2.5 | -3.15 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 3 | 3 | 3 | 2 |
| Up Last 30 Days | 3 | 3 | 3 | 2 |
| Down Last 7 Days | 1 | 1 | 1 | 2 |
| Down Last 30 Days | 1 | 1 | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SEPN | -- | -- | 74.13% | -34.66% |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 3/28/2025 |
| Downgrade | Wells Fargo: Overweight to Equal-Weight | 2/18/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 2/11/2025 |
| Initiated | Cantor Fitzgerald: Overweight | 11/19/2024 |
| Initiated | Wells Fargo: Overweight | 11/19/2024 |
| Initiated | JP Morgan: Overweight | 11/19/2024 |
Related Tickers
SION Sionna Therapeutics, Inc.
12.32
-1.99%
MBX MBX Biosciences, Inc.
11.11
-5.12%
UPB Upstream Bio, Inc.
8.82
-0.23%
RAPP Rapport Therapeutics, Inc.
10.25
-3.76%
MAZE Maze Therapeutics, Inc.
9.62
-3.99%
AARD Aardvark Therapeutics, Inc.
10.42
-2.89%
TCRX TScan Therapeutics, Inc.
1.2700
-7.97%
SYRE Spyre Therapeutics, Inc.
14.10
+9.64%
MTSR Metsera, Inc.
23.87
-3.59%
OVID Ovid Therapeutics Inc.
0.2901
-1.33%